As of 2025-07-01, the Relative Valuation of Acceleron Pharma Inc (XLRN) is (52.97) USD. This relative valuation is based on P/E multiples. With the latest stock price at 178.75 USD, the upside of Acceleron Pharma Inc based on Relative Valuation is -129.6%.
The range of the Relative Valuation is (52.76) - (54.87) USD.
Note: valuation result may not be accurate due to the company's negative earnings.
| Range | Selected | |
| Trailing P/E multiples | 12.5x - 13.3x | 12.9x |
| Forward P/E multiples | 11.4x - 13.0x | 12.2x |
| Fair Price | (52.76) - (54.87) | (52.97) |
| Upside | -129.5% - -130.7% | -129.6% |
| Date | P/E |